News and Events
- March 14, 2017
TCGA Investigators Improve Understanding of the Molecular Drivers of Cholangiocarcinoma
Investigators with The Cancer Genome Atlas (TCGA) Research Network characterized 58 cholangiocarcinomas, rare cancers of bile ducts, and identified a new subtype characterized by mutation of the IDH gene.
- March 13, 2017
TCGA Study of Rare Uterine Cancer Identifies Molecular Features
The Cancer Genome Atlas (TCGA) Research Network comprehensively characterized 57 uterine carcinosarcomas and found that these rare cancers share molecular features with both sarcomas and carcinomas.
- February 02, 2017
TCGA study identifies four subtypes of rare nervous system cancers
Researchers with The Cancer Genome Atlas Network determined that pheochromocytomas (PCC) and paragangliomas (PGL) can be classified into four distinct subtypes and also found several novel alterations never before seen in these rare cancers of the autonomic nervous system.
- June 10, 2015
Brain Tumor’s Genetic Makeup Critical in Treatment, Research Finds
The New York Times describes the important findings from TCGA's research on lower grade gliomas.
- January 27, 2015
Warning: That Tan Could Be Hazardous
The New York Times reports on TCGA data bolstering the case for the link between melanoma and ultraviolet light exposure.
- October 06, 2014
Cancer Genome Sequencing Will Mean More Targeted Therapies
Forbes interviews Dr. Carolyn Hutter, NHGRI team lead for TCGA, about the influence of cancer genomics on the future of precision medicine.
Histopathological image of cerebral glioblastoma.
View All Images >
The difference between a normal cell and cancer cell and how understanding the changes in DNA that cause cancer can help doctors develop better treatments.
View All Videos >
| From the NIH
View All Audio >